Os Therapies Incorporated
(OSTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 95 | 100 | 39 | 0 | 0 |
| Other current assets | 1,179 | 941 | 751 | 0 | 0 |
| TOTAL | $1,336 | $1,042 | $790 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 7 | 7 | 8 | N/A | N/A |
| TOTAL | $7 | $7 | $8 | $N/A | $N/A |
| Total Assets | $1,342 | $1,049 | $798 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 250 | 100 | N/A | 0 | 0 |
| Accounts payable and accrued liabilities | 2,925 | 2,799 | 2,715 | 0 | 0 |
| Accrued Expenses | 188 | 163 | 163 | 0 | 0 |
| Other current liabilities | 5,836 | 5,561 | 5,054 | 0 | 0 |
| TOTAL | $28,306 | $26,455 | $24,714 | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 100 | 100 | 100 | 0 | 0 |
| TOTAL | $100 | $100 | $100 | $N/A | $N/A |
| Total Liabilities | $28,406 | $26,555 | $24,814 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,885 | 11,982 | N/A | N/A | N/A |
| Common Shares | 6 | 12 | 5 | 0 | 0 |
| Retained earnings | -32,566 | -31,008 | -29,518 | 0 | 0 |
| TOTAL | $-27,064 | $-25,507 | $-24,016 | $0 | $0 |
| Total Liabilities And Equity | $1,342 | $1,049 | $798 | $0 | $0 |